ArticleSurgery2024

Sodium-glucose co-transporter 2 inhibitor canagliflozin modulates myocardial metabolism and inflammation in a swine model for chronic myocardial ischemia.

Dwight D Harris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.